@FierceBiotech: Roche extends biotech shopping spree with $8.3B InterMune buyout. News | Follow @FierceBiotech
@JohnCFierce: Getting the feeling today that the slower summer news cycle is coming to a close. | Follow @JohnCFierce
@EmilyMFierce: ICYMI: UCSF spinout launches crowdfunding campaign for Ebola drug. Story | Follow @EmilyMFierce
> Beijing-based FortuneRock said it had raised $24 million to back its development work as well as spin off a new enterprise to build a GMP manufacturing center in Tianjin. Release
> Leading an effort at the conservative Manhattan Institute to reform the FDA, former FDA chief Andrew von Eschenbach (who served under George W. Bush) says that the agency has become too "risk averse" and is holding biotechs back with demands for large studies. Story
Medical Device News
@FierceMedDev: ICYMI: FDA approves more innovative med tech, faster in first half. Story | Follow @FierceMedDev
@VarunSaxena2: Covidien acquisition of Reverse Medical illustrates vascular device focus. Article | Follow @VarunSaxena2
@EmilyWFierce: $MDT shareholders rail against company's pending merger with $COV. Story via Pioneer Press | Follow @EmilyWFierce
> Chinese physicians implant first 3-D printed vertebrae in child. Story
> Endo reported to be selling its AMS med-dev unit. Article
> FDA approves more innovative med tech, faster in first half. More
Pharma News
@FiercePharma: Top-read over the weekend: Pfizer eyes Actavis in backup plan to another AstraZeneca bid. More | Follow @FiercePharma
@TracyStaton: Novo Nordisk CEO on the house that Victoza built and the future of diabetes R&D. Article via FierceBiotech | Follow @TracyStaton
@EricPFierce: As EvaluatePharma figures, 2014 could rival 2009 in M&A action, and that is a lot. More | Follow @EricPFierce
@CarlyHFierce: ICYMI: Valeant, Ackman pass threshold to call pivotal Allergan meeting. Story | Follow @CarlyHFierce
> Roche ready to roll on InterMune's lung drug with $8.6B buyout deal. Story
> Glaxo's ViiV venture adds $5B combo pill to its HIV-fighting armory. Article
> Jumping into global M&A mix key to India growing its pharma industry. More
CRO News
> Quintiles and Illumina look to jump-start cancer R&D with genomics sweepstakes. Article
> Evotec teams up with malaria nonprofit in open R&D project. Report
> Parexel: Biotech's boom pays dividends for CROs. More
> CRO PharPoint signs up to get Otologic's hearing drug into the clinic. Story
> Clinverse reels in a $9.1M funding round to expand its trial tech. Article
Biotech IT News
> Illumina teams with AstraZeneca, J&J and Sanofi on cancer diagnostic. More
> Rollout of openFDA continues with drug labeling, medtech adverse event APIs. Article
> Clinverse and Comprehend raise $30M in separate financing rounds. More
> uBiome raises $4.5M as first batch of Y Combinator biotechs pitch to investors. Story
> Rock Health backs cloud-based R&D platform as Abbott comes on board. Article
Animal Health News
> Merck releases tilapia vaccine. News
> China's Skystar Bio-Pharmaceutical sees revenue grow 25%. Report
> FDA warns Kentucky drug compounder after sick, dead horses reported. Article
> Boehringer Ingelheim's Vetmedica to open $30M facility near Kansas City. Story
> Kinavet CA-1 moves forward to trials. Item